Intravesical chemotherapy for carcinoma of the bladder--duration of the treatment course.
作者信息
Jakse G
出版信息
Prog Clin Biol Res. 1985;185B:69-78.
PMID:3898142
Abstract
摘要
相似文献
1
Intravesical chemotherapy for carcinoma of the bladder--duration of the treatment course.
Prog Clin Biol Res. 1985;185B:69-78.
2
Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?
Prog Clin Biol Res. 1985;185B:47-55.
3
Intravesical chemotherapy for superficial bladder tumors category Ta/T1: who should be treated and how?Ta/T1期浅表性膀胱肿瘤的膀胱内化疗：哪些患者应接受治疗以及如何治疗？
Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):30-5.
4
Risk-adapted use of intravesical chemotherapy.膀胱内化疗的风险适应性应用。
BJU Int. 2008 Nov;102(9 Pt B):1247-53. doi: 10.1111/j.1464-410X.2008.07967.x.
5
6
What matters - early start or duration of chemotherapy instillation regimens or patient characteristics?什么更重要——化疗灌注方案的早期开始、持续时间还是患者特征？
Eur Urol. 2008 May;53(5):882-5; discussion 885-6. doi: 10.1016/j.eururo.2008.01.042. Epub 2008 Jan 22.
7
Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?非肌层浸润性膀胱癌的膀胱内化疗：治疗方案及疗程是怎样的？
Eur Urol. 2007 Oct;52(4):951-3; discussion 953-4. doi: 10.1016/j.eururo.2007.03.028. Epub 2007 Mar 15.
8
9
[Intravesical therapy: Influence on superficial bladder cancer recurrence].膀胱内灌注治疗：对浅表性膀胱癌复发的影响
Arch Esp Urol. 2007 Jan-Feb;60(1):36-43.
10
Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation.膀胱内化疗与卡介苗免疫疗法对浅表性膀胱移行细胞癌复发的影响：荟萃分析再评估
Am J Clin Oncol. 2003 Aug;26(4):402-7. doi: 10.1097/01.COC.0000026911.98171.C6.
引用本文的文献
1
Superficial bladder cancer: state of the art.浅表性膀胱癌：最新进展
Cancer Chemother Pharmacol. 1994;35 Suppl:S101-9. doi: 10.1007/BF00686931.
Zotero 插件